Brenda Panzera, M.D.
NPI 1962502013 · Hematology & Oncology Physician · New York, NY
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Brenda Panzera, M.D. is a Hematology & Oncology Physician provider in New York, NY (NPI 1962502013).
Provider details
- NPI number
- 1962502013
- Entity type
- Individual
- Primary specialty
- Hematology & Oncology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Female
- Sole proprietor
- No
- License
- 212086 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
32,214 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Flow Cytometry Technique for Dna Or Cell Analysis, Each Additional Marker88185 | 4,676 | $28 |
| Insertion of Needle Into Vein for Collection of Blood Sample36415 | 2,222 | $9 |
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 2,155 | $8 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 2,056 | $10 |
| Gammaglobulin (immune System Protein) Measurement82784 | 1,461 | $9 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 1,434 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 22 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Anastrozole | 234 | 61 |
| Darbepoetin Alfa in Polysorbatbrand: Aranesp | 114 | 18 |
| Letrozole | 72 | 26 |
| Apixabanbrand: Eliquis | 64 | 14 |
| Fulvestrant | 59 | — |
| Exemestane | 46 | 11 |
| Fosnetupitant/Palonosetronbrand: Akynzeo | 31 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-09-25
- Last updated
- 2007-07-08
Frequently asked questions
- What is Brenda Panzera's NPI number?
- Brenda Panzera's National Provider Identifier (NPI) is 1962502013, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Brenda Panzera's specialty?
- Brenda Panzera is listed in the NPPES registry with a primary specialty of Hematology & Oncology Physician (Allopathic & Osteopathic Physicians).
- Where is Brenda Panzera located?
- Brenda Panzera's practice location on file with NPPES is 1050 Park Avenue, New York, NY 10028.
- What is Brenda Panzera's phone number?
- The practice phone number listed in the NPPES registry for Brenda Panzera is (212) 860-3292.
- Does Brenda Panzera accept Medicare?
- Brenda Panzera is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Brenda Panzera's NPI active?
- Yes — Brenda Panzera's NPI (1962502013) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.